Bayer Investing More Than $45M CAD to Build World-Class Canola Research and Development Facility in Canada
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260127786960/en/
Bayer announced an unprecedented $45+ million CAD investment to strengthen Canada’s leadership in canola innovation by establishing a cutting-edge canola innovation centre.
“A long-term strategic investment of this scale demonstrates Bayer’s commitment to Canadian canola and to the farmers who depend on it,” said
Design for the new facility will begin in 2026 and we anticipate it to be operational by the end of 2028. It consolidates some of our canola breeding operations and seed generation activities, allowing Bayer to continue our journey to get the full benefit of our precision breeding strategy to bring products to market for growers in
Bayer’s current Smartpark site in
About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all, Hunger for none,” the company’s products and services are designed to help people, and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2024, the Group employed around 93,000 people and had sales of
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260127786960/en/
For further information or to arrange an interview, contact:
mediacanada@bayer.com
Source: Bayer